Surfactant protein D in respiratory and non-respiratory diseases
GL Sorensen - Frontiers in medicine, 2018 - frontiersin.org
Surfactant protein D (SP-D) is a multimeric collectin that is involved in innate immune
defense and expressed in pulmonary, as well as non-pulmonary, epithelia. SP-D exerts …
defense and expressed in pulmonary, as well as non-pulmonary, epithelia. SP-D exerts …
Chronic obstructive pulmonary disease biomarkers and their interpretation
RA Stockley, DMG Halpin, BR Celli… - American journal of …, 2019 - atsjournals.org
The pathology and impact of chronic obstructive pulmonary disease (COPD) results from an
abnormal inflammatory process resulting in tissue damage with ineffective repair in …
abnormal inflammatory process resulting in tissue damage with ineffective repair in …
At the root: defining and halting progression of early chronic obstructive pulmonary disease
FJ Martinez, MLK Han, JP Allinson, RG Barr… - American journal of …, 2018 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a prevalent, heterogeneous disorder with
varying presentation and progression but with a limited number of disease-modifying …
varying presentation and progression but with a limited number of disease-modifying …
[HTML][HTML] Animal models reflecting chronic obstructive pulmonary disease and related respiratory disorders: translating pre-clinical data into clinical relevance
Chronic obstructive pulmonary disease (COPD) affects the lives of an ever-growing number
of people worldwide. The lack of understanding surrounding the pathophysiology of the …
of people worldwide. The lack of understanding surrounding the pathophysiology of the …
Diagnosis and treatment of early chronic obstructive lung disease (COPD)
Chronic obstructive lung disease (COPD) is responsible for substantial rates of mortality and
economic burden, and is one of the most important public-health concerns. As the disease …
economic burden, and is one of the most important public-health concerns. As the disease …
The AGE-RAGE axis and RAGE genetics in chronic obstructive pulmonary disease
A Sharma, S Kaur, M Sarkar, BC Sarin… - Clinical Reviews in …, 2021 - Springer
Chronic obstructive pulmonary disease (COPD) is a heterogeneous group of lung diseases
limiting the airflow due to narrowing of airways, chronic bronchitis and emphysema that …
limiting the airflow due to narrowing of airways, chronic bronchitis and emphysema that …
Protein biomarkers for COPD outcomes
KA Serban, KA Pratte, RP Bowler - Chest, 2021 - Elsevier
COPD is a clinically heterogeneous syndrome characterized by injury to airways, airspaces,
and lung vasculature and usually caused by tobacco smoke and/or air pollution exposure …
and lung vasculature and usually caused by tobacco smoke and/or air pollution exposure …
Omics and the search for blood biomarkers in chronic obstructive pulmonary disease. Insights from COPDGene
There is an unmet need for blood biomarkers in diagnosis and prognosis of chronic
obstructive pulmonary disease (COPD). The search for these biomarkers has been …
obstructive pulmonary disease (COPD). The search for these biomarkers has been …
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
Background Soluble receptor for advanced glycation end products (sRAGE) is a proposed
emphysema and airflow obstruction biomarker; however, previous publications have shown …
emphysema and airflow obstruction biomarker; however, previous publications have shown …
Advances in design strategies of multiplex electrochemical aptasensors
I Grabowska, M Hepel, K Kurzątkowska-Adaszyńska - Sensors, 2021 - mdpi.com
In recent years, the need for simple, fast, and economical detection of food and
environmental contaminants, and the necessity to monitor biomarkers of different diseases …
environmental contaminants, and the necessity to monitor biomarkers of different diseases …